Economic evaluation of fulvestrant as an extra step in the treatment sequence for ER-positive advanced breast cancer.
Cameron DA, Camidge DR, Oyee J, Hirsch M. Economic evaluation of fulvestrant as an extra step in the treatment sequence for ER-positive advanced breast cancer. Br J Cancer. 2008 Dec 16; 99(12):1984-90.